Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singapore Institute Of Advanced Medicine Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was S$-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was S$-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was -16.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
SGX:9G2'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -44.2 Med: -30.4 Max: -16.6
Current: -16.6
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Singapore Institute Of Advanced Medicine Holdings was -16.60% per year. The lowest was -44.20% per year. And the median was -30.40% per year.
SGX:9G2's 3-Year EBIT Growth Rate is ranked worse than 84.51% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs SGX:9G2: -16.60
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Singapore Institute Of Advanced Medicine Holdings EBIT per Share Related Terms
Singapore Institute Of Advanced Medicine Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings EBIT per Share Chart
Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend
Jun21
Jun22
Jun23
Jun24
Jun25
EBIT per Share
-0.01
-0.01
-0.02
-0.03
-0.02
Singapore Institute Of Advanced Medicine Holdings Quarterly Data
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a EBIT per Share of S$-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #442 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 84.5%.
Is Singapore Institute Of Advanced Medicine Holdings' EBIT per Share too high?
Singapore Institute Of Advanced Medicine Holdings' current EBIT per Share is S$-0.01. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #442 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #442 out of 523 companies for EBIT per Share. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current EBIT per Share is S$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current EBIT per Share of S$-0.01. The current EBIT per Share is S$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current EBIT per Share is S$-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:9G2 has been successfully added to your 
